Clinical trial
Predictive Assay for Decision Making in Adjuvant Therapy (PADMA)
NCT05032352 is registered in ClinicalTrials.gov with Insight Molecular Diagnostics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictive Assay for Decision Making in Adjuvant Therapy (PADMA)
- Lead sponsor
- Insight Molecular Diagnostics
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 28, 2022
- Completion date
- October 28, 2022
- Enrollment
- 55 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.